ID26313A - Tablet untuk pembebasan dengan segera dan yang diperlambat dari satu atau lebih substansi aktif - Google Patents

Tablet untuk pembebasan dengan segera dan yang diperlambat dari satu atau lebih substansi aktif

Info

Publication number
ID26313A
ID26313A IDW20001144A ID20001144A ID26313A ID 26313 A ID26313 A ID 26313A ID W20001144 A IDW20001144 A ID W20001144A ID 20001144 A ID20001144 A ID 20001144A ID 26313 A ID26313 A ID 26313A
Authority
ID
Indonesia
Prior art keywords
slowed
tablets
active substance
immediate release
immediate
Prior art date
Application number
IDW20001144A
Other languages
English (en)
Indonesian (id)
Inventor
Olivier Saslawski
Laurence Orlando
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID26313A publication Critical patent/ID26313A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
IDW20001144A 1997-12-23 1998-12-11 Tablet untuk pembebasan dengan segera dan yang diperlambat dari satu atau lebih substansi aktif ID26313A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9716402A FR2772615B1 (fr) 1997-12-23 1997-12-23 Comprime multicouche pour la liberation instantanee puis prolongee de substances actives

Publications (1)

Publication Number Publication Date
ID26313A true ID26313A (id) 2000-12-14

Family

ID=9515042

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001144A ID26313A (id) 1997-12-23 1998-12-11 Tablet untuk pembebasan dengan segera dan yang diperlambat dari satu atau lebih substansi aktif

Country Status (24)

Country Link
US (1) US6372255B1 (cs)
EP (1) EP1041972B1 (cs)
JP (1) JP4451563B2 (cs)
KR (1) KR100574207B1 (cs)
CN (1) CN1163220C (cs)
AR (1) AR017897A1 (cs)
AT (1) ATE223207T1 (cs)
AU (1) AU743195B2 (cs)
BR (1) BR9814345A (cs)
CA (1) CA2316277C (cs)
CZ (1) CZ291884B6 (cs)
DE (1) DE69807747T2 (cs)
DK (1) DK1041972T3 (cs)
ES (1) ES2182397T3 (cs)
FR (1) FR2772615B1 (cs)
HU (1) HU226069B1 (cs)
ID (1) ID26313A (cs)
NO (1) NO20003289L (cs)
PT (1) PT1041972E (cs)
RU (1) RU2212885C2 (cs)
SK (1) SK283236B6 (cs)
UA (1) UA55503C2 (cs)
WO (1) WO1999033448A1 (cs)
ZA (1) ZA9811799B (cs)

Families Citing this family (172)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
WO2001013901A2 (en) * 1999-08-20 2001-03-01 Ferrosan A/S A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress
CA2383212C (en) * 1999-09-02 2008-11-25 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
IL148864A0 (en) * 1999-09-28 2002-09-12 Panacea Biotec Ltd Pharmaceutical compositions containing nimesulide
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
EP1138330A1 (en) * 1999-12-23 2001-10-04 Warner-Lambert Company Combination of trimebutine with an opioid analgesic
ES2270982T3 (es) * 2000-02-04 2007-04-16 Depomed, Inc. Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20070141107A1 (en) * 2000-03-15 2007-06-21 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
ES2220789T3 (es) * 2000-10-30 2004-12-16 Lupin Limited Composicion de cefuroxima axetilo de liberacion lenta que se desintegra rapidamente.
KR100778835B1 (ko) * 2000-12-28 2007-11-22 엘지.필립스 엘시디 주식회사 액정표시장치의 제조방법
KR100685945B1 (ko) 2000-12-29 2007-02-23 엘지.필립스 엘시디 주식회사 액정표시장치 및 그 제조방법
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
BR0207297A (pt) 2001-02-15 2005-04-19 King Pharmaceuticals Inc Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
EP1383483A4 (en) * 2001-04-05 2006-08-09 Collagenex Pharm Inc CONTROLLED RELEASE OF TETRACYCLIN COMPOUNDS AND TETRACYCLINE DERIVATIVES
CA2343949A1 (en) * 2001-04-12 2002-10-12 Bernard Charles Sherman Benazepril hydrochloride tablet formulations
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030180356A1 (en) * 2001-10-29 2003-09-25 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
PE20040134A1 (es) 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
AU2003272504A1 (en) * 2002-09-20 2004-04-08 Andrx Labs Llc Multistage formulation containing a biguanide and thiazolidindione derivatives
SE0203065D0 (sv) * 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
MXPA02010828A (es) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
US20040115265A1 (en) * 2002-12-11 2004-06-17 Loutfy Benkerrour Multilayered tablet containing pravastatin and aspirin and method
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
EP1575566B1 (en) * 2002-12-26 2012-02-22 Pozen, Inc. Multilayer dosage forms containing naproxen and triptans
TWI355276B (en) * 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
WO2004064815A1 (en) * 2003-01-21 2004-08-05 Smartrix Technologies Inc. Oral dosage formulation
KR20050123097A (ko) * 2003-02-11 2005-12-29 알자 코포레이션 변형된 층 형상을 갖는 방법 및 제형
FR2851734B1 (fr) * 2003-02-28 2006-06-09 Galenix Innovations Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
CA2518734A1 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
US20040192781A1 (en) * 2003-03-31 2004-09-30 Haley Eugene T. Method of administration for metoclopramide and pharmaceutical formulation therefor
CA2521885C (en) 2003-04-07 2013-06-25 Shire Laboratories, Inc. Once daily formulations of tetracyclines
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
US6863830B1 (en) * 2003-08-21 2005-03-08 Biolab Services, Inc. Dual layer tablet, method of making and use thereof
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
KR20060115860A (ko) * 2003-09-26 2006-11-10 알자 코포레이션 활성 제제의 서방성 전달을 위한 ｏｒｏｓ 푸시-스틱
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050084531A1 (en) * 2003-10-16 2005-04-21 Jatin Desai Tablet with aqueous-based sustained release coating
RU2260431C2 (ru) * 2003-12-15 2005-09-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления
CA2552630A1 (en) * 2004-01-06 2005-07-21 Panacea Biotec Ltd. Non-disintegrating oral solid composition of high dose of water soluble drugs
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
US20050226929A1 (en) * 2004-04-12 2005-10-13 Jianbo Xie Controlled release opioid analgesic formulation
WO2005099672A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
SI1591109T1 (sl) * 2004-04-30 2008-10-31 Topotarget Germany Ag Formulacija, ki obsega inhibitor histon-deacetilaze in izkazuje dvofazno sproščanje
RU2267318C1 (ru) * 2004-05-25 2006-01-10 Закрытое акционерное общество "ФАРМАПЭК" Пролонгированный антиангинальный препарат изосорбида динитрата и способ его получения
FR2873113B1 (fr) * 2004-07-19 2007-06-15 Eurotab Sa Produit solide compacte bicouche de purification d'eau
US20060020007A1 (en) * 2004-07-26 2006-01-26 Roger Berlin Compositions containing policosanol and biotin and their pharmaceutical uses
NZ553561A (en) * 2004-08-13 2010-12-24 Boehringer Ingelheim Int Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
KR20070048272A (ko) 2004-09-01 2007-05-08 유로-셀띠끄 소시에떼 아노님 용량 비례적 정상 상태 Ｃａｖｅ및 ＡＵＣ를 갖고, 용량비례적 단일 용량 Ｃｍａｘ보다 작은 오피오이드성 제형
RU2280440C1 (ru) * 2004-12-23 2006-07-27 Закрытое акционерное общество Научный Центр "ФармВИЛАР" Средство "би-коден", обладающее противокашлевым и отхаркивающим действием
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
BRPI0606932A2 (pt) * 2005-01-26 2009-07-28 Elan Pharma Int Ltd formulação, forma de dosagem, e, uso de uma quantidade terapeuticamente efetiva de uma formulação
RU2314805C2 (ru) * 2005-01-28 2008-01-20 Арсалан Гармаевич Цындымеев Диуретическое и гипотензивное средство пролонгированного действия
RU2281772C1 (ru) * 2005-02-14 2006-08-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
JP5597343B2 (ja) * 2005-04-28 2014-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有する組成物
EP1888045B1 (en) * 2005-05-24 2010-09-08 Flamel Technologies Oral pharmaceutical composition for treating a cox-2 mediated condition
RU2370268C2 (ru) * 2005-05-25 2009-10-20 Лабораториос Баго С.А. Способ получения фармацевтической композиции для орального введения, обладающей улучшенной биодоступностью биологически активного действующего лекарственного вещества, и фармацевтическая композиция, полученная этим способом
RU2286150C1 (ru) * 2005-06-03 2006-10-27 Зимин Дмитрий Владимирович Лекарственная форма пролонгированного действия, обладающая диуретической, вазодилатирующей и гипотензивной активностью, и способ ее изготовления
US20070020333A1 (en) * 2005-07-20 2007-01-25 Chin-Chih Chiang Controlled release of hypnotic agents
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
PT1931346E (pt) * 2005-09-09 2012-08-14 Angelini Labopharm Llc Composição de trazodona para administração uma vez por dia
JP2009507047A (ja) * 2005-09-09 2009-02-19 ラボファーム インコーポレイテッド 持続性薬物放出組成物
CA2620018A1 (en) * 2005-09-28 2007-04-12 Mali Kadosh Stable combinations of amlodipine besylate and benazepril hydrochloride
DE102005048293A1 (de) * 2005-10-08 2007-04-12 Sanofi-Aventis Deutschland Gmbh Retardformulierung für Pralnacasan
US8148393B2 (en) * 2005-11-18 2012-04-03 Synthon Bv Zolpidem tablets
UA12297U (en) * 2005-11-24 2006-01-16 Pharma Start Ltd Liability Com Matrix tablet providing for delayed release of trimetasin
WO2007073702A2 (es) 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
CZ300698B6 (cs) * 2006-06-16 2009-07-22 Zentiva, A. S. Tableta s obsahem metforminu
FR2906801B1 (fr) * 2006-10-05 2008-12-12 Eurotab Sa Produit solide compacte bicouche de potabilisaton d'eau et procede de preparation.
CA2664893C (en) 2006-10-30 2015-01-27 Hanall Pharmaceutical Company, Ltd. Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
US8394845B2 (en) 2006-10-30 2013-03-12 Hanall Biopharma Co., Ltd. Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
CN101631549B (zh) * 2007-03-15 2012-08-22 东洋纺织株式会社 贴附于口腔粘膜的丁丙诺非制剂的制造方法
WO2008142627A2 (en) * 2007-05-17 2008-11-27 Ranbaxy Laboratories Limited Multilayered modified release formulation comprising amoxicillin and clavulanate
AU2008261957A1 (en) 2007-06-08 2008-12-18 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
US8404275B2 (en) 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
WO2009024858A1 (en) * 2007-08-22 2009-02-26 Aurobindo Pharma Limited Controlled release dosage form of galantamine
US8895066B2 (en) * 2007-10-16 2014-11-25 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
RU2377989C2 (ru) * 2007-11-27 2010-01-10 Товарыство з обмэжэною видповидальнистю "Фарма Старт" Лекарственное средство триметазидина в форме матриксной таблетки с пролонгированным действием и способ его получения
CN101969930A (zh) * 2007-12-17 2011-02-09 莱博法姆公司 防滥用控制释放制剂
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
WO2009154810A2 (en) * 2008-02-25 2009-12-23 Dr. Reddy's Laboratories Ltd. Delivery systems for multiple active agents
WO2009118764A1 (en) * 2008-03-28 2009-10-01 Panacea Biotec Limited Pharmaceutical composition comprising diclofenac and paracetamol
JP2009256237A (ja) * 2008-04-16 2009-11-05 Daiichi Sankyo Healthcare Co Ltd 固形製剤
WO2010019915A1 (en) 2008-08-15 2010-02-18 Depomed Inc. Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
WO2010045656A2 (en) * 2008-10-17 2010-04-22 Nectid, Inc. Novel sglt2 inhibitor dosage forms
WO2010053337A2 (ko) * 2008-11-10 2010-05-14 (주)아모레퍼시픽 서방성 미립자 및 이의 제조방법
EP2367541B1 (en) 2008-12-16 2014-07-16 Paladin Labs Inc. Misuse preventative, controlled release formulation
CN102292074B (zh) * 2009-01-23 2013-08-21 霍夫曼-拉罗奇有限公司 包含阿格列扎的药物组合物
KR101050076B1 (ko) * 2009-02-04 2011-07-19 한국유나이티드제약 주식회사 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
WO2010138441A1 (en) * 2009-05-28 2010-12-02 Aptapharma, Inc. Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen
CN102638978A (zh) * 2009-06-25 2012-08-15 波曾公司 用于治疗需要阿司匹林治疗之患者的方法
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US8741343B2 (en) 2009-12-02 2014-06-03 Adamas Pharmaceuticals, Inc. Method of administering amantadine prior to a sleep period
WO2011080716A2 (en) 2010-01-04 2011-07-07 Wockhardt Limited Pharmaceutical composition for modified delivery of actives
US20110274751A1 (en) * 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles
JP2013533241A (ja) 2010-06-22 2013-08-22 ティダブリューアイ・ファーマシューティカルズ・インコーポレイテッド 食物効果が減少した制御放出組成物
CN102727496A (zh) * 2011-04-12 2012-10-17 上海双健现代药物技术咨询有限公司 一种复方抗结核药口服固体制剂及其制备方法
EP2770978B1 (en) 2011-10-28 2018-01-10 Vitalis LLC Anti-flush compositions
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
ES2558204T3 (es) * 2012-01-31 2016-02-02 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulaciones de comprimido bicapa de flurbiprofeno y glucosamina
WO2013124768A1 (en) * 2012-02-20 2013-08-29 Lupin Limited Bilayer tablet of dronedarone
BR112014020186A8 (pt) 2012-02-22 2017-07-11 Duchesnay Inc Formulação de doxilamina e piridoxina e/ou seus metabólitos ou sais
US20140072671A1 (en) * 2012-06-29 2014-03-13 Adam Auerbach Multi-component oral delivery systems and uses thereof
WO2014075155A1 (pt) * 2012-11-14 2014-05-22 Diffucap Chemobras Química E Farmacêutica Ltda Combinação farmacêutica contendo agente analgésico e agente antiespasmódico
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
RU2521572C1 (ru) * 2012-12-21 2014-06-27 Федеральное государственное бюджетное учреждение науки Институт химии растворов им. Г.А. Крестова Российской академии наук (ИХР РАН) Сокристаллическая форма фенбуфена
US20160022621A1 (en) * 2013-03-12 2016-01-28 Biohit Oyj Composition for oral administration for binding aldehydes in the gastrointestinal tract
CN105228917B (zh) 2013-04-29 2018-07-03 克拉瑞特产品（法国）有限公司 容器的容器帽
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
US9452181B2 (en) 2013-07-22 2016-09-27 Duchesnay Inc. Composition for the management of nausea and vomiting
EP3024466B1 (en) 2013-07-22 2018-04-04 Duchesnay Inc. Composition for the management of nausea and vomiting
WO2015027303A1 (pt) * 2013-08-28 2015-03-05 Diffucap Chemobras Quimica E Farmaceutica Ltda Procedimento. de fabricação de combinação farmacêutica contendo agente analgésico e agente antiespasmódico e combinação farmacêutica
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
JP6272561B2 (ja) * 2014-08-29 2018-01-31 デュシネイ・インコーポレイテッド ドキシラミン並びにピリドキシン及び／またはそれらの代謝産物もしくは塩の多峰性放出製剤
US9526703B2 (en) * 2014-08-29 2016-12-27 Duchesnay Inc. Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US9132096B1 (en) 2014-09-12 2015-09-15 Alkermes Pharma Ireland Limited Abuse resistant pharmaceutical compositions
CA2936746C (en) * 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10413403B2 (en) * 2015-07-14 2019-09-17 Boston Scientific Scimed, Inc. Prosthetic heart valve including self-reinforced composite leaflets
RU2690159C1 (ru) * 2015-07-23 2019-05-31 Атена Драг Деливери Солюшнз Пвт Лтд. Композиция золпидема и способ ее получения
KR102636273B1 (ko) * 2017-03-08 2024-02-16 신알엑스 파마, 엘엘씨 플로로글루시놀 및 트리메틸플로로글루시놀의 제약 제제
MX2020002078A (es) 2017-08-24 2020-09-21 Adamas Pharma Llc Composiciones de amantadina, preparaciones de estas y métodos de uso.
US11819482B2 (en) 2017-08-29 2023-11-21 Conrig Pharma Aps Composition comprising suplatast tosilate
CN114845704A (zh) * 2019-12-19 2022-08-02 赛特瑞恩股份有限公司 包含西苯唑啉或其盐的药物制剂
CN114432300B (zh) * 2022-02-16 2023-08-01 平顶山市第二人民医院 含有比索洛尔和依那普利的药物组合物及其工艺
CN120859963B (zh) * 2025-09-26 2025-12-09 湖南状元制药有限公司 甲钴胺缓释微片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
FR2645152B1 (fr) * 1989-03-30 1991-05-31 Lipha 3h-pteridinones-4, procedes de preparation et medicaments les contenant
CA2277220A1 (en) * 1997-01-10 1998-07-16 Abbott Laboratories Tablet for the controlled release of active agents

Also Published As

Publication number Publication date
JP4451563B2 (ja) 2010-04-14
ATE223207T1 (de) 2002-09-15
HUP0100406A2 (hu) 2001-08-28
ES2182397T3 (es) 2003-03-01
UA55503C2 (uk) 2003-04-15
CN1163220C (zh) 2004-08-25
AU2160699A (en) 1999-07-19
JP2001527034A (ja) 2001-12-25
CA2316277A1 (en) 1999-07-08
CN1283110A (zh) 2001-02-07
EP1041972A1 (en) 2000-10-11
CZ291884B6 (cs) 2003-06-18
DK1041972T3 (da) 2003-01-06
DE69807747D1 (de) 2002-10-10
ZA9811799B (en) 1999-06-22
BR9814345A (pt) 2000-10-03
CZ20002332A3 (cs) 2000-10-11
RU2212885C2 (ru) 2003-09-27
DE69807747T2 (de) 2003-06-12
PT1041972E (pt) 2003-01-31
SK283236B6 (sk) 2003-04-01
AR017897A1 (es) 2001-10-24
NO20003289D0 (no) 2000-06-22
HU226069B1 (en) 2008-04-28
WO1999033448A1 (en) 1999-07-08
US6372255B1 (en) 2002-04-16
FR2772615B1 (fr) 2002-06-14
KR20010033532A (ko) 2001-04-25
FR2772615A1 (fr) 1999-06-25
SK9322000A3 (en) 2001-04-09
CA2316277C (en) 2008-07-08
AU743195B2 (en) 2002-01-24
KR100574207B1 (ko) 2006-04-27
NO20003289L (no) 2000-08-22
EP1041972B1 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
ID26313A (id) Tablet untuk pembebasan dengan segera dan yang diperlambat dari satu atau lebih substansi aktif
ID26945A (id) Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan
BR9600100B1 (pt) composição de revestimento de açúcar para aplicação a um tablete medicinal comprimido e tablete comprimido.
AU5609998A (en) Tablet for the controlled release of active agents
NO2011010I1 (no) Naproksen- og esomeprazoltabletter med modifisert frisetting
NO20012168D0 (no) Innretning for regulert avgivelse av aktive stoffer
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
IS5524A (is) Forðatöflur til inntöku
ATE268161T1 (de) Bioadhäsive tabletten
GB9706942D0 (en) Active matrix devices
AP9801173A0 (en) Rapidly releasing and taste-making pharmaceutical dosage
NZ288144A (en) Active agent sustained release capsule: fluid expandable layers and active agent layers
PL346545A1 (en) Immediate release tablet
IS5248A (is) Lyfjasamsetningar sem innihalda vorikónasól
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
ID22233A (id) Tablet telan yang terdiri dari parasetamol
PL374778A1 (en) Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
HUP0002719A3 (en) Controlled release pharmaceutical preparation with ace inhibitor as active agent
HUP0100184A3 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds and pharmaceuticals comprising them
KR960702322A (ko) 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하며 약효가 개선된 정제 (more easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent)
HUP9901715A3 (en) Layered tablet for the controlled release of active substances
CA2185242A1 (en) Sustained release tablet containing diclofenac-na
HUP0100564A3 (en) Matrix metalloproteinase inhibitors and pharmaceuticals comprising them